ℹ️
🇬🇧
Search
Search for people relevant for "CBR1"
CBR1
Person
Class
Person
Publication
Programmes
Export current view
prof. Ing. Vladimír Wsól Ph.D.
Academic staff at Faculty of Pharmacy in Hradec Králové
2 study programmes
14 classes
198 publications
Study programme
programme
Xenobiochemistry and Pathobiochemistry
+1
🇨🇿 PhD. |
Faculty of Pharmacy in Hradec Králové
Classes
class
General Biochemistry
+1
GAF141 |
Faculty of Pharmacy in Hradec Králové
class
Xenobiochemistry
+1
GAF237 |
Faculty of Pharmacy in Hradec Králové
class
Xenobiochemistry - Practical Training
+3
GAF267 |
Faculty of Pharmacy in Hradec Králové
class
Selected Chapters from General Biochemistry
+1
GDEXP04 |
Faculty of Pharmacy in Hradec Králové
class
The Defense of Doctoral Thesis
+1
GDEXPODP1 |
Faculty of Pharmacy in Hradec Králové
class
Xenobiochemistry and Patobiochemistry
+1
GDEXPSDZ1 |
Faculty of Pharmacy in Hradec Králové
Load more classes (4)
Publications
publication
Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro
2013 |
Faculty of Pharmacy in Hradec Králové
publication
Efficient isolation of carbonyl-reducing enzymes using affinity approach with anticancer drug oracin as a specific ligand
2013 |
Faculty of Pharmacy in Hradec Králové
publication
S-Nitrosoglutathione covalently modifies cysteine residues of human carbonyl reductase 1 and affects its activity
2013 |
Faculty of Pharmacy in Hradec Králové
publication
Studies on reduction of S-nitrosoglutathione by human carbonyl reductases 1 and 3
2011 |
Faculty of Pharmacy in Hradec Králové
publication
Human carbonyl reductases
2010 |
Central Library of Charles University
publication
Structural basis for substrate specificity in human monomeric carbonyl reductases
2009 |
Central Library of Charles University
publication
Bruton's Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux
2022 |
Faculty of Pharmacy in Hradec Králové
publication
Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters
2022 |
Faculty of Pharmacy in Hradec Králové
publication
Inhibition of AKR1B10-mediated metabolism of daunorubicin as a novel off-target effect for the Bcr-Abl tyrosine kinase inhibitor dasatinib
2021 |
Faculty of Pharmacy in Hradec Králové
publication
Selective inhibition of aldo-keto reductase 1C3: a novel mechanism involved in midostaurin and daunorubicin synergism
2021 |
Faculty of Pharmacy in Hradec Králové
Load more publications (188)
Loading network view...